GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 27 weeks, 41kg, and endpoint was the hard part — 18 comments in the full submission. View in context.
643
c/trialwatch·submitted 1 year ago by u/adaeze_weiss

[Results] 27 weeks, 41kg, and endpoint was the hard part

Readoutbranch of 7 comments

Trying to settle this properly because the thread from last year went in circles. The claim: FLOW matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 13 months without either producing anything. What would actually settle it is 39 people measuring the same…

Read the full submission and all 18 comments →

This branch

7 comments, started 1 year ago
u/trialwatch_theoMOD31 points·1 year ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/bastian_ekstrom26 points·1 year ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/iman_castellanos35 points·1 year ago·edited

What was the dropout rate?

replysharereportpermalink
u/rohan_steiner21 points·1 year ago

event rates are more informative than hazard ratios alone

replysharereportpermalink
u/adaeze_weissOP-23 points·1 year ago

What was the dropout rate?

replysharereportpermalink
u/joaquin_stanescu0 points·1 year ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/nordic_pricing27 points·1 year ago·edited

number-needed-to-treat is the house dialect

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.